Replies to post #30195 on Marker Therapeutics Inc (MRKR)

[microcapbiotech]

I don't know, I read the article. There was nothing new there. Except for discontinuing the platinum-sensitive trial and the temporary FDA hold, (both of which we knew about), the article was factual. The cons we knew about and are in the past now, and the pros are still out there and happening and yet to be seen. We knew about their cash and the stock purchase deal with Aspire Capital (which I still think was a very good arranged deal for Marker, to be able to control the when and how much).

The article didn't give me any "new" hope, but it didn't take away any hope that I had.

BTW, article here:
https://seekingalpha.com/article/4352378-revisiting-marker-therapeutics

[floridajim1]

Thanks for your response.